Anonymous
Guest
Anonymous
Guest
I don't think captain obvious gets it. JnJ never claimed or has any delusions about owning the market. We have yet to see if there really will be a leader in a disease state where cocktails of all the new therapies aspire to help patients be treated with out interferon.
No doubt Gilead has a huge pipeline dedicated to HCV but other therapies should not be knocked out as players as the future for most will be used in combo.
Get off your high horse and get ready.
No doubt Gilead has a huge pipeline dedicated to HCV but other therapies should not be knocked out as players as the future for most will be used in combo.
Get off your high horse and get ready.